Benitec Biopharma Ltd ADR (BNTC) — Capital Reinvestment Ratio

Latest as of September 2018: 0.00x

Benitec Biopharma Ltd ADR (BNTC) has a Capital Reinvestment Ratio of 0.00x as of September 2018, meaning it reinvests 0% of its operating cash flow ($5.87 Million) in capital expenditures ($26.00K). Check Benitec Biopharma Ltd ADR tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$5.87 Million

USD

Capital Expenditures

$26.00K

USD

Data as of

Sep 2018

Most recent filing

Benitec Biopharma Ltd ADR Capital Reinvestment Ratio (2019–2019)

This chart tracks Benitec Biopharma Ltd ADR's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Benitec Biopharma Ltd ADR cash conversion from operations.

Annual Capital Reinvestment Ratio for Benitec Biopharma Ltd ADR (2019–2019)

Year-by-year Capital Reinvestment Ratio for Benitec Biopharma Ltd ADR from 2019 to 2019. See Benitec Biopharma Ltd ADR free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2019	0.08x	$4.79 Million	$403.40K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow